Literature DB >> 21364190

An important role of lymphatic vessel activation in limiting acute inflammation.

Reto Huggenberger1, Shoib S Siddiqui, Daniela Brander, Stefan Ullmann, Kathrin Zimmermann, Maria Antsiferova, Sabine Werner, Kari Alitalo, Michael Detmar.   

Abstract

In contrast to the established role of blood vessel remodeling in inflammation, the biologic function of the lymphatic vasculature in acute inflammation has remained less explored. We studied 2 established models of acute cutaneous inflammation, namely, oxazolone-induced delayed-type hypersensitivity reactions and ultraviolet B irradiation, in keratin 14-vascular endothelial growth factor (VEGF)-C and keratin 14-VEGF-D transgenic mice. These mice have an expanded network of cutaneous lymphatic vessels. Transgenic delivery of the lymphangiogenic factors VEGF-C and the VEGFR-3 specific ligand mouse VEGF-D significantly limited acute skin inflammation in both experimental models, with a strong reduction of dermal edema. Expression of VEGFR-3 by lymphatic endothelium was strongly down-regulated at the mRNA and protein level in acutely inflamed skin, and no VEGFR-3 expression was detectable on inflamed blood vessels and dermal macrophages. There was no major change of the inflammatory cell infiltrate or the composition of the inflammatory cytokine milieu in the inflamed skin of VEGF-C or VEGF-D transgenic mice. However, the increased network of lymphatic vessels in these mice significantly enhanced lymphatic drainage from the ear skin. These results provide evidence that specific lymphatic vessel activation limits acute skin inflammation via promotion of lymph flow from the skin and reduction of edema formation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21364190      PMCID: PMC3099581          DOI: 10.1182/blood-2010-10-316356

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor.

Authors:  Tatiana V Petrova; Taija Mäkinen; Tomi P Mäkelä; Janna Saarela; Ismo Virtanen; Robert E Ferrell; David N Finegold; Dontscho Kerjaschki; Seppo Ylä-Herttuala; Kari Alitalo
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

2.  Angiogenesis and remodeling of airway vasculature in chronic inflammation.

Authors:  D M McDonald
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

3.  Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis.

Authors:  Yu-Ping Xia; Baosheng Li; Donna Hylton; Michael Detmar; George D Yancopoulos; John S Rudge
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

4.  Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates.

Authors:  Dontscho Kerjaschki; Heinrich M Regele; Isabella Moosberger; Katalyn Nagy-Bojarski; Bruno Watschinger; Afschin Soleiman; Peter Birner; Sigurd Krieger; Anny Hovorka; Georg Silberhumer; Pirjo Laakkonen; Tatiana Petrova; Brigitte Langer; Ingrid Raab
Journal:  J Am Soc Nephrol       Date:  2004-03       Impact factor: 10.121

5.  Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia.

Authors:  Rainer Kunstfeld; Satoshi Hirakawa; Young-Kwon Hong; Vivien Schacht; Bernhard Lange-Asschenfeldt; Paula Velasco; Charles Lin; Edda Fiebiger; Xunbin Wei; Yan Wu; Daniel Hicklin; Peter Bohlen; Michael Detmar
Journal:  Blood       Date:  2004-04-20       Impact factor: 22.113

6.  Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival.

Authors:  Claus Cursiefen; Jingtai Cao; Lu Chen; Ying Liu; Kazuichi Maruyama; David Jackson; Friedrich E Kruse; Stanley J Wiegand; M Reza Dana; J Wayne Streilein
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-08       Impact factor: 4.799

7.  VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment.

Authors:  Claus Cursiefen; Lu Chen; Leonardo P Borges; David Jackson; Jingtai Cao; Czeslaw Radziejewski; Patricia A D'Amore; M Reza Dana; Stanley J Wiegand; J Wayne Streilein
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

8.  Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells.

Authors:  Pedram Hamrah; Lu Chen; Qiang Zhang; M Reza Dana
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

9.  Ultraviolet B-induced skin angiogenesis is associated with a switch in the balance of vascular endothelial growth factor and thrombospondin-1 expression.

Authors:  Kiichiro Yano; Kentaro Kajiya; Miki Ishiwata; Young-Kwon Hong; Tokichi Miyakawa; Michael Detmar
Journal:  J Invest Dermatol       Date:  2004-01       Impact factor: 8.551

10.  Contact sensitivity in the mouse. IV. The role of lymphocytes and macrophages in passive transfer and the mechanism of their interaction.

Authors:  G L Asherson; M Zembala
Journal:  J Exp Med       Date:  1970-07-01       Impact factor: 14.307

View more
  103 in total

Review 1.  The new era of the lymphatic system: no longer secondary to the blood vascular system.

Authors:  Inho Choi; Sunju Lee; Young-Kwon Hong
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

Review 2.  The lymphatic vasculature in disease.

Authors:  Kari Alitalo
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

3.  The orphan adhesion G protein-coupled receptor GPR97 regulates migration of lymphatic endothelial cells via the small GTPases RhoA and Cdc42.

Authors:  Nadejda Valtcheva; Adriana Primorac; Giorgia Jurisic; Maija Hollmén; Michael Detmar
Journal:  J Biol Chem       Date:  2013-10-31       Impact factor: 5.157

4.  Vascular endothelial growth factor-C ameliorates renal interstitial fibrosis through lymphangiogenesis in mouse unilateral ureteral obstruction.

Authors:  Shoko Hasegawa; Toshiaki Nakano; Kumiko Torisu; Akihiro Tsuchimoto; Masahiro Eriguchi; Naoki Haruyama; Kosuke Masutani; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  Lab Invest       Date:  2017-10-30       Impact factor: 5.662

5.  Obesity increases inflammation and impairs lymphatic function in a mouse model of lymphedema.

Authors:  Ira L Savetsky; Jeremy S Torrisi; Daniel A Cuzzone; Swapna Ghanta; Nicholas J Albano; Jason C Gardenier; Walter J Joseph; Babak J Mehrara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-05-23       Impact factor: 4.733

6.  VEGF-C mediated enhancement of lymphatic drainage reduces intestinal inflammation by regulating IL-9/IL-17 balance and improving gut microbiota in experimental chronic colitis.

Authors:  Xiaolei Wang; Jin Zhao; Li Qin
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

7.  Non-invasive dynamic near-infrared imaging and quantification of vascular leakage in vivo.

Authors:  Steven T Proulx; Paola Luciani; Annamari Alitalo; Viviane Mumprecht; Ailsa J Christiansen; Reto Huggenberger; Jean-Christophe Leroux; Michael Detmar
Journal:  Angiogenesis       Date:  2013-01-17       Impact factor: 9.596

8.  Inflammation and Lymphedema Are Exacerbated and Prolonged by Neuropilin 2 Deficiency.

Authors:  Patrick Mucka; Nicholas Levonyak; Elena Geretti; Bernadette M M Zwaans; Xiaoran Li; Irit Adini; Michael Klagsbrun; Rosalyn M Adam; Diane R Bielenberg
Journal:  Am J Pathol       Date:  2016-10-14       Impact factor: 4.307

Review 9.  Congenital chylothorax treated with oral sildenafil: a case report and review of the literature.

Authors:  D T Malleske; B A Yoder
Journal:  J Perinatol       Date:  2015-05       Impact factor: 2.521

10.  Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal lymphatic drainage.

Authors:  Susan N Thomas; Joseph M Rutkowski; Miriella Pasquier; Emma L Kuan; Kari Alitalo; Gwendalyn J Randolph; Melody A Swartz
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.